Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Diabetes
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Diabetes
    Darbepoetin Alfa Risks Outweigh Benefits for Patients With CKD, Diabetes, and Anaemia: Presented at Renal Week 2009 - (DGDispatch)
    Fenofibrate May Protect Diabetics Against Loss of Renal Function: Presented at Renal Week 2009 - (DGDispatch)
    A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease - (N Engl J Med)
    TopAbstracts in Diabetes 11/03/2009 - (DGNews)
    Paricalcitol Added to Hypertension Therapy Lowers Albuminuria in Patients With Diabetes and Chronic Kidney Disease: Presented at Renal Week 2009 - (DGDispatch)

    News archive

     Recent webcasts/CME - Diabetes
    • Optimizing Insulin-Dependent Diabetes Management in Long-Term Care
    • Insulin-Dependent Diabetes in Long-Term Care: Scope of the Problem and Effective Management
    • Cases in Practice: Incretin-Based Therapies for Common Patient Encounters
      Diabetes Management - Pearls of Lipid Control
      Obesity Management in Patients with Type 2 Diabetes

      Webcasts/CME archive

       Recent cases - Diabetes
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        A Patient Presenting with Symptomatic Hypomagnesemia Caused by Metformin-Induced Diarrhoea: A Case Report
        Absence of Diabetic Retinopathy in a Patient who has had Diabetes Mellitus for 69 Years, and Inadequate Glycemic Control: Case Report
        Gallbladder Edema in Type 1 Diabetic Patient due to Delayed-type Insulin Allergy
        Compound Heterozygous Mutation of Aquaporin 2 Gene in Woman Patient with Congenital Nephrogenic Diabetes Insipidus

        Cases archive
          




        my personal edition > diabetes > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Metabolic Markers May Help Identify Insulin Resistance in Overweight Individuals

        A DGReview of :"Use of metabolic markers to identify overweight individuals who are insulin resistant"
        Annals of Internal Medicine

        11/24/2003
        By Keely S. Solomon, PhD


        Easily measured metabolic markers may be useful for identifying overweight individuals who are insulin resistant and likely to benefit from weight loss counselling, according to a recent American study.

        Insulin resistance is an independent predictor for both type 2 diabetes and cardiovascular disease (CVD), and it has been shown to occur more frequently in overweight individuals. Although weight loss can significantly decrease insulin resistance and the associated health risks, many physicians do not provide weight loss counselling for overweight patients.

        "Reluctance to assign weight control programs a high priority might be decreased if identifying overweight or obese individuals at greatest risk were possible," writes Tracey McLaughlin, MD, of Stanford University School of Medicine, California. However, detection of insulin resistance by direct measurement of insulin-mediated glucose disposal is often not clinically practical.

        To address this concern, Dr. McLaughlin and colleagues evaluated the ability of several metabolic markers to identify overweight individuals who are both insulin resistant and at greatest risk for CVD.

        Metabolic markers were measured in 258 overweight or obese nondiabetic individuals (mean age, 50 years; 127 men) and statistically evaluated for associations with insulin resistance, estimated by a modified insulin suppression test.

        Of the 8 markers analysed in the study, insulin concentration, plasma triglyceride concentration, and the ratio of triglyceride to high-density lipoprotein (HDL) cholesterol concentrations were found to be 3 most useful for identifying insulin resistance. The sensitivity of the markers was 67%, 64%, and 57% for triglycerides, triglyceride-HDL cholesterol ratio, and insulin, respectively, and specificities were 71%, 68%, and 85%.

        According to Dr. McLaughlin, the optimal cut-off values for identifying insulin resistance were 1.47 mmol/L for triglycerides, 1.8 in SI units for triglyceride-HDL ratio, and 109 pmol/L for insulin.

        Although plasma insulin was found to be the marker most closely associated with insulin resistance, the researchers note that, "the absence of a standardized insulin assay significantly hampers the clinical utility of plasma insulin."

        However, they emphasise that both plasma triglyceride and triglyceride-HDL cholesterol ratio gave specificity and sensitivity similar to the Adult Treatment Panel III criteria proposed to diagnose the metabolic syndrome (sensitivity, 52%; specificity, 85%). Both markers are additionally known to be associated with an increased risk for cardiovascular disease.

        "The relatively more consistent association between low HDL cholesterol level and CVD makes the triglyceride-HDL cholesterol ratio a clinically appealing marker for CVD risk in addition to insulin resistance," the researchers conclude.

        Ann Intern Med 2003 Nov 18;139:10:802-9. "Use of metabolic markers to identify overweight individuals who are insulin resistant"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send